1. Home
  2. VRDN vs AMR Comparison

VRDN vs AMR Comparison

Compare VRDN & AMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRDN
  • AMR
  • Stock Information
  • Founded
  • VRDN 2006
  • AMR 2016
  • Country
  • VRDN United States
  • AMR United States
  • Employees
  • VRDN N/A
  • AMR N/A
  • Industry
  • VRDN Medical Specialities
  • AMR Coal Mining
  • Sector
  • VRDN Health Care
  • AMR Energy
  • Exchange
  • VRDN Nasdaq
  • AMR Nasdaq
  • Market Cap
  • VRDN 1.0B
  • AMR 1.5B
  • IPO Year
  • VRDN N/A
  • AMR N/A
  • Fundamental
  • Price
  • VRDN $13.92
  • AMR $112.04
  • Analyst Decision
  • VRDN Strong Buy
  • AMR Buy
  • Analyst Count
  • VRDN 12
  • AMR 2
  • Target Price
  • VRDN $38.50
  • AMR $181.00
  • AVG Volume (30 Days)
  • VRDN 838.2K
  • AMR 292.5K
  • Earning Date
  • VRDN 05-06-2025
  • AMR 05-09-2025
  • Dividend Yield
  • VRDN N/A
  • AMR N/A
  • EPS Growth
  • VRDN N/A
  • AMR N/A
  • EPS
  • VRDN N/A
  • AMR 2.04
  • Revenue
  • VRDN $302,000.00
  • AMR $2,625,170,000.00
  • Revenue This Year
  • VRDN N/A
  • AMR N/A
  • Revenue Next Year
  • VRDN $21,976.14
  • AMR $16.32
  • P/E Ratio
  • VRDN N/A
  • AMR $54.91
  • Revenue Growth
  • VRDN 4.86
  • AMR N/A
  • 52 Week Low
  • VRDN $9.90
  • AMR $100.00
  • 52 Week High
  • VRDN $27.20
  • AMR $334.72
  • Technical
  • Relative Strength Index (RSI)
  • VRDN 55.94
  • AMR 39.68
  • Support Level
  • VRDN $13.37
  • AMR $112.53
  • Resistance Level
  • VRDN $14.18
  • AMR $121.95
  • Average True Range (ATR)
  • VRDN 0.67
  • AMR 5.23
  • MACD
  • VRDN 0.14
  • AMR -0.83
  • Stochastic Oscillator
  • VRDN 85.65
  • AMR 0.55

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).

About AMR Alpha Metallurgical Resources Inc.

Alpha Metallurgical Resources Inc is a Tennessee-based coal mining company with operations across Virginia and West Virginia. The company's portfolio of mining operations consists of underground mines, surface mines, and coal preparation plants. It produces low-ash metallurgical coal, including High-Vol. A, Mid-Vol., High-Vol. B, and Low-Vol. coal, which is shipped to domestic and international coke and steel producers. The reportable segment of the company is Met. It extracts, processes and markets met and thermal coal from deep and surface mines for sale to steel and coke producers, industrial customers, and electric utilities.

Share on Social Networks: